{"id":"NCT02658175","sponsor":"Akcea Therapeutics","briefTitle":"The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome","officialTitle":"ISIS 304801-CS7 The APPROACH Open Label Study Volanesorsen (ISIS 304801) An Open-Label Study of Volanesorsen Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12-23","primaryCompletion":"2020-01-15","completion":"2020-01-15","firstPosted":"2016-01-18","resultsPosted":"2021-08-26","lastUpdate":"2021-08-26"},"enrollment":68,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Familial Chylomicronemia Syndrome","Lipoprotein Lipase Deficiency","Hyperlipoproteinemia Type 1"],"interventions":[{"type":"DRUG","name":"Volanesorsen","otherNames":["IONIS-APOCIIIRx","ISIS 304801"]}],"arms":[{"label":"Treatment-naïve Group","type":"EXPERIMENTAL"},{"label":"CS6-Volanesorsen","type":"EXPERIMENTAL"},{"label":"CS16-Volanesorsen","type":"EXPERIMENTAL"}],"summary":"An open-label study of volanesorsen (ISIS 304801) administered subcutaneously to participants with FCS.","primaryOutcome":{"measure":"Mean Percent Change From Baseline in Fasting Triglyceride (TG)","timeFrame":"Baseline and Months 3, 6, and 12","effectByArm":[{"arm":"Treatment-naïve Group","deltaMin":-59.8,"sd":37},{"arm":"CS6-Volanesorsen","deltaMin":-49.2,"sd":34.8},{"arm":"CS16-Volanesorsen","deltaMin":-64.9,"sd":9.1}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":34,"countries":["United States","Brazil","Canada","France","Germany","Israel","Italy","Netherlands","South Africa","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":51},"commonTop":["Injection site erythema","Nasopharyngitis","Injection site pain","Abdominal pain","Injection site swelling"]}}